Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifeward Ltd (LFWD)

Lifeward Ltd (LFWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,623
  • Shares Outstanding, K 18,294
  • Annual Sales, $ 25,660 K
  • Annual Income, $ -28,940 K
  • EBIT $ -20 M
  • EBITDA $ -16 M
  • 60-Month Beta 0.00
  • Price/Sales 0.33
  • Price/Cash Flow N/A
  • Price/Book 0.87
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.97
  • Most Recent Earnings $-0.20 on 11/14/25
  • Next Earnings Date 03/06/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Options Overview Details

View History
  • Implied Volatility 509.49% (+105.06%)
  • Historical Volatility 81.37%
  • IV Percentile 97%
  • IV Rank 57.19%
  • IV High 863.80% on 10/14/25
  • IV Low 36.19% on 10/13/25
  • Expected Move (DTE 34) 0.0425 (6.16%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 101
  • Volume Avg (30-Day) 40
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 4,910
  • Open Int (30-Day) 4,829
  • Expected Range 0.6475 to 0.7325

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -1.73
  • Growth Rate Est. (year over year) +95.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5573 +23.81%
on 12/30/25
0.7410 -6.88%
on 01/13/26
+0.0502 (+7.85%)
since 12/16/25
3-Month
0.5050 +36.63%
on 11/13/25
0.7900 -12.66%
on 12/05/25
-0.0201 (-2.83%)
since 10/16/25
52-Week
0.5010 +37.72%
on 06/25/25
2.9500 -76.61%
on 03/13/25
-1.1200 (-61.88%)
since 01/16/25

Most Recent Stories

More News
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended...

ORMP : 3.68 (-0.27%)
LFWD : 0.6900 (-4.50%)
Lifeward Appoints Bob Marshall as Chairman of the Board

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology...

LFWD : 0.6900 (-4.50%)
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will...

LFWD : 0.6900 (-4.50%)
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for  47% of all Medicare Advantage enrollees This...

LFWD : 0.6900 (-4.50%)
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...

LFWD : 0.6900 (-4.50%)
Lifeward: Q3 Earnings Snapshot

Lifeward: Q3 Earnings Snapshot

LFWD : 0.6900 (-4.50%)
Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established  Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%...

LFWD : 0.6900 (-4.50%)
Lifeward to Report Third Quarter Financial Results on November 14, 2025

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...

LFWD : 0.6900 (-4.50%)
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM...

LFWD : 0.6900 (-4.50%)
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform...

LFWD : 0.6900 (-4.50%)

Business Summary

Lifeward designs, develops and commercializes life-changing solutions which span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. The company's portfolio features products including...

See More

Key Turning Points

3rd Resistance Point 0.7814
2nd Resistance Point 0.7557
1st Resistance Point 0.7228
Last Price 0.6900
1st Support Level 0.6642
2nd Support Level 0.6385
3rd Support Level 0.6056

See More

52-Week High 2.9500
Fibonacci 61.8% 2.0145
Fibonacci 50% 1.7255
Fibonacci 38.2% 1.4365
Last Price 0.6900
52-Week Low 0.5010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar